Single-Dose AAV-MECP2 Safety/Tolerability and Efficacy in Rett Syndrome
Clinical trial NCT06856759 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06856759
- Sponsor
- Guangzhou Women and Children's Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-14
- Primary completion
- 2026-10-20
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.